Improving the in vitro and in vivo performance of a 177Lu-labeled phosphoramidate-based PSMA inhibitor with an albumin-binding motif

被引：0
|
作者：
Choy, Cindy [1 ]
Ling, Xiaoxi [2 ]
Geruntho, Jonathan [2 ]
Beyers, Sophia [1 ]
Latoche, Joseph [2 ]
Langton-Webster, Beatrice [1 ]
Anderson, Carolyn [2 ]
Berkman, Clifford [1 ]
机构：
[1] Canc Targeted Technol, Woodinville, WA USA
[2] Univ Pittsburgh, Radiol, Pittsburgh, PA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2017年 / 253卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
275
引用
收藏
页数：1
相关论文
共 39 条
  • [1] SPECT/CT imaging of 177Lu-labeled phosphoramidate-based PSMA inhibitor with an albumin-binding motif
    Ling, Xiaoxi
    Choy, Cindy
    Latoche, Joseph
    Geruntho, Jonathan
    Wu, Yijen
    Salamacha, Nathan
    Langton-Webster, Beatrice
    Anderson, Carolyn
    Berkman, Clifford
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [2] Comparison of traditional and albumin-binding Lu-177-labeled phosphoramidate-based PSMA inhibitors for targeted radionuclide therapy of prostate cancer
    Ling, Xiaoxi
    Choy, Cindy
    Geruntho, Jonathan
    Beyer, Sophia
    Latoche, Joseph
    Langton-Webster, Beatrice
    Anderson, Carolyn
    Berkman, Clifford
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [3] 177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice
    Choy, Cindy J.
    Ling, Xiaoxi
    Geruntho, Jonathan J.
    Beyer, Sophia K.
    Latoche, Joseph D.
    Langton-Webster, Beatrice
    Anderson, Carolyn J.
    Berkman, Clifford E.
    THERANOSTICS, 2017, 7 (07): : 1928 - 1939
  • [4] Preclinical Evaluation of a New Series of Albumin-Binding 177Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics
    Boinapally, Srikanth
    Alati, Suresh
    Jiang, Zirui
    Yan, Yu
    Lisok, Alla
    Singh, Rajan
    Lofland, Gabriela
    Minn, Il
    Hobbs, Robert F.
    Pomper, Martin G.
    Banerjee, Sangeeta Ray
    MOLECULES, 2023, 28 (16):
  • [5] Evaluation of the effect of the addition of an albumin-binding motif on 177Lu-DOTATATE
    Rousseau, Etienne
    Lau, Joseph
    Zhang, Zhengxing
    Uribes, Carlos
    Kuo, Hsiou-Ting
    Zeisler, Jutta
    Colpo, Nadine
    Lin, Kuo-Shyan
    Benard, Francois
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [6] Enhancing Treatment Efficacy of 177Lu-PSMA-617 with the Conjugation of an Albumin-Binding Motif: Preclinical Dosimetry and Endoradiotherapy Studies
    Kuo, Hsiou-Ting
    Merkens, Helen
    Zhang, Zhengxing
    Uribe, Carlos F.
    Lau, Joseph
    Zhang, Chengcheng
    Colpo, Nadine
    Lin, Kuo-Shyan
    Benard, Francois
    MOLECULAR PHARMACEUTICS, 2018, 15 (11) : 5183 - 5191
  • [7] Enhancing treatment efficacy of 177Lu-PSMA-617 with the conjugation of an albumin-binding motif: preclinical dosimetry and endoradiotherapy studies
    Kuo, H.
    Merkens, H.
    Zhang, Z.
    Uribe, C.
    Zhang, C.
    Lau, J.
    Colpo, N.
    Benard, F.
    Lin, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S53 - S53
  • [8] Prospects of medium specific activity 177Lu in targeted therapy of prostate cancer using 177Lu-labeled PSMA inhibitor
    Chakraborty, Sudipta
    Chakravarty, Rubel
    Shetty, Priyalata
    Vimalnath, K. V.
    Sen, Ishita B.
    Dash, Ashutosh
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2016, 59 (09): : 364 - 371
  • [9] Enhanced Therapeutic Effect of the Albumin-Binding [177Lu]Lu-Ibu-DAB-PSMA as Compared to [177Lu]Lu-PSMA-617-A Preclinical Therapy Study
    Tschan, V.
    Borgna, F.
    Schibli, R.
    Mueller, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S65 - S66
  • [10] Combined Application of Albumin-Binding [177Lu]Lu-PSMA-ALB-56 and Fast-Cleared PSMA Inhibitors: Optimization of the Pharmacokinetics
    Borgna, Francesca
    Deberle, Luisa M.
    Cohrs, Susan
    Schibli, Roger
    Muller, Cristina
    MOLECULAR PHARMACEUTICS, 2020, 17 (06) : 2044 - 2053
1234